Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.65 |
| ▸ | LTA4H | P09960 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.57 |
| ▸ | GAA | P10253 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | GLA | P06280 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 4/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | CASP1 | P29466 | 2/20 | 0.55 |
| ▸ | CASP7 | P55210 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13942801 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL13707359 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL15957843 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL1105086 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL2742433 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL23611278 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL14703073 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL13707354 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| Alpha-Terthienyl SCHEMBL147274 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL13707356 | 1.00 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11605813-B2 | Silicon-based energy storage devices with functional terthiophene compound or thiophene oligomer compound containing electrolyte additives | ENEVATE CORPORATION (US) | 2023-03-14 | — | — | US | claimed |
| CN-114380982-A | Photopatternable Organic Semiconductor (OSC) polymers, methods of forming the same, and uses thereof | 康宁股份有限公司 | 2022-04-22 | — | — | CN | claimed |
| US-20200388836-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL TERTHIOPHENE COMPOUND OR THIOPHENE OLIGOMER COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| EP-2482856-B1 | MICELLAR COMPOSITIONS FOR USE IN BIOLOGICAL APPLICATIONS | KING S COLLEGE LONDON (GB) | 2015-07-08 | — | — | EP | claimed |
| US-20120269736-A1 | MICELLAR COMPOSITIONS FOR USE IN BIOLOGICAL APPLICATIONS | KING'S COLLEGE LONDON (GB) | 2012-10-25 | — | — | US | claimed |
| EP-2482856-A2 | MICELLAR COMPOSITIONS FOR USE IN BIOLOGICAL APPLICATIONS | KINGS COLLEGE LONDON (GB) | 2012-08-08 | — | — | EP | claimed |
| WO-2011039535-A2 | MICELLAR COMPOSITIONS FOR USE IN BIOLOGICAL APPLICATIONS | KING'S COLLEGE LONDON (GB) | 2011-04-07 | — | — | WO | claimed |
| US-20260047337-A1 | MANAGING 2D/3D HETEROSTRUCTURE ENERGY LANDSCAPE VIA PI-CONJUGATED ORGANIC CATIONS FOR EFFICIENT PEROVSKITE SOLAR CELLS | PURDUE RESEARCH FOUNDATION | 2026-02-12 | — | — | US | disclosed |
| US-20250354873-A1 | TEMPERATURE INTEGRITY SENSOR | UNIVERSITÀ DEGLI STUDI DI CAGLIARI (IT) | 2025-11-20 | — | — | US | disclosed |
| US-20250344597-A1 | SOLUTION-PROCESSED PEROVSKITE HETEROSTRUCTURES | WILLIAM MARSH RICE UNIVERSITY (US) | 2025-11-06 | — | — | US | disclosed |
| US-12435100-B2 | Perovskite solar cells | PURDUE RESEARCH FOUNDATION (US) | 2025-10-07 | — | — | US | disclosed |
| US-20250250262-A1 | ORGANIC COMPOUND, OPTO-ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS INCLUDING THE OPTO-ELECTRONIC DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-08-07 | — | — | US | disclosed |
| US-12336406-B2 | Display | JSR CORPORATION (JP) | 2025-06-17 | — | — | US | disclosed |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | QLT INC. (CA) | 2002-02-21 | — | — | US | disclosed |
| WO-2001085213-A2 | SUPPORTS FOR PHOTOSENSITIZER FORMULATIONS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001035996-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001035997-A2 | USE OF LOW-DOSE PDT TO INHIBIT RESTENOSIS | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| EP-0668277-B1 | Bipyridyl-oligothiophene derivatives as electron-conducting materials | VALTION TEKNILLINEN (FI) | 1998-11-04 | — | — | EP | disclosed |
| US-5556524-A | DIAGNOSTICS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1996-09-17 | — | — | US | disclosed |
| EP-0668277-A1 | Bipyridyl-oligothiophene derivatives as electron-conducting materials | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1995-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250354873-A1 | TEMPERATURE INTEGRITY SENSOR | CUTA, LRBA, TREH | DPP4 3328/4885LTA4H 3310/4885ALDH1A1 3892/4885 |
| US-20260047337-A1 | MANAGING 2D/3D HETEROSTRUCTURE ENERGY LANDSCAPE VIA PI-CONJUGATED ORGANIC CATIONS FOR EFFICIENT PEROVSKITE SOLAR CELLS | SLC9A3, ITGB4, SLC9A2 | DPP4 902/4885LTA4H 4098/4885ALDH1A1 2546/4885 |
| US-20250250262-A1 | ORGANIC COMPOUND, OPTO-ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS INCLUDING THE OPTO-ELECTRONIC DEVICE | OR10J3, OR51E2, OCIAD1 | DPP4 3505/4885LTA4H 1273/4885ALDH1A1 82/4885 |
| US-12435100-B2 | Perovskite solar cells | BCL3, MCL1, ANXA3 | DPP4 4468/4885LTA4H 3786/4885ALDH1A1 2526/4885 |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | CD74, ANXA11, ANXA1 | DPP4 1489/4885LTA4H 846/4885ALDH1A1 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.